SELLAS Life Sciences Group Inc (NASDAQ:SLS) has a beta value of 2.19 and has seen 1.28 million shares traded in the last trading session. The company, currently valued at $82.15M, closed the last trade at $1.46 per share which meant it lost -$0.06 on the day or -3.95% during that session. The SLS stock price is -30.82% off its 52-week high price of $1.91 and 65.75% above the 52-week low of $0.50. The 3-month trading volume is 1.47 million shares.
SELLAS Life Sciences Group Inc (NASDAQ:SLS) trade information
Sporting -3.95% in the red in last session, the stock has traded in the red over the last five days, when the SLS stock price touched $1.46 or saw a rise of 15.12%. Year-to-date, SELLAS Life Sciences Group Inc shares have moved 37.74%, while the 5-day performance has seen it change -5.19%. Over the past 30 days, the shares of SELLAS Life Sciences Group Inc (NASDAQ:SLS) have changed 41.75%.
SELLAS Life Sciences Group Inc (SLS) estimates and forecasts
Figures show that SELLAS Life Sciences Group Inc shares have outperformed across the wider relevant industry. The company’s shares have gained 62.22% over the past 6 months, with this year growth rate of 35.07%, compared to 12.90% for the industry. Other than that, the company has, however, increased its growth outlook for the 2024 fiscal year revenue. Growth estimates for the current quarter are 55.30% and 35.50% for the next quarter.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 61.44% over the past 5 years.
SLS Dividends
SELLAS Life Sciences Group Inc is expected to release its next earnings report in May this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
